Skip to content
Thursday 13 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,833.15
-0.10%
DAX
26,331.07
-0.23%
CAC 40
8,674.94
-0.46%
STOXX 50
6,533.99
-0.26%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Monday 06 July 2020 8:38 am

Aviva CEO Maurice Tulloch steps down with immediate effect for ‘family health reasons’

By: Joe Curtis

Add as a preferred source on Google

Aviva chief executive Maurice Tulloch has stepped down from the role with immediate effect for “family health reasons”, the insurance giant said today.

Non-executive director Amanda Blanc will take on the CEO role from today, Aviva said, after joining the board at the start of the year.

She was previously CEO, EMEA & Global Banking Partnerships at Zurich Insurance Group. Prior to that Blanc served as group CEO of AXA UK, PPP and Ireland and has served as chair of the Association of British Insurers and president of the Chartered Insurance Institute.

Aviva boss Tulloch said he would step aside due to family health reasons.

The insurance veteran took on the top job in March 2019 after heading up Aviva’s international division. He joined Aviva’s board in 2017 after serving in a number of roles at the insurer since 1992.

Blanc said: “Aviva is a great company, full of great people, and I’m honoured to be given the opportunity to help shape its future. I want Aviva to be the leader in our industry again and the first choice for our customers and partners. My focus will be on achieving that for the benefit of all of our stakeholders.

“We will look at all our strategic opportunities, and at pace. I have been on the Aviva board since the start of this year and have a good understanding of where the business has its strengths and what actions we should take across our portfolio.”

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

George Culmer, chairman of Aviva, thanked Tulloch for his “valuable contribution”, adding: “The board and I were saddened to hear of the personal reasons behind his desire to step down and we wish him and his family the very best for the future.

“We are delighted that Amanda will be our new CEO. The board was unanimous in endorsing her appointment. I know she will bring real dynamism to Aviva and re-establish our credentials as a high-performing, innovative and customer-centric business.”

Aviva shares rose 4.1 per cent to 284.7p in early trading today.

Tulloch embarked on a management shake-up following his appointment as CEO in 2019 in a bid to deliver greater value to shareholders. And he announced 1,800 job cuts to save £300m per year as Aviva seeks to cut £1.5bn from its debt pile by 2022.

The insurer revealed a record full-year operating profit of £3.18bn in March but warned it would take a £500,000 hit from coronavirus.

Later it warned coronavirus could cost it as much as £160m.

Main image of Maurice Tulloch. Credit: Aviva

Read more

Clinigen Appoints Greg Skalicky as Chief Executive Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Aviva

Trending Articles

  • Government debt repayment ‘could rise to half’ of total taxes

  • Everest Group Announces Dividend

  • Moody’s Corporation Elects Keith Demmings to Board of Directors

  • Lattice to Deliver Keynote at 2026 OCP Global Summit

  • Martin Williams on his favourite Toast the City venues

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Clinigen Appoints Greg Skalicky as Chief Executive Officer

    Business Wire
  • Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development

    Business Wire
  • QX Global Group Appoints Vijay Pahuja as Group Chief Executive Officer

    Business Wire
  • Hiscox finance chief: London’s AI adoption is too slow

    Opinion
    Paul Cooper, a man in a navy suit, gestures during a business meeting at a conference table.
  • Jacob Parsons Appointed Global CEO of Indicium AI

    Business Wire
  • SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO

    Business Wire
  • Moody’s Corporation Elects Keith Demmings to Board of Directors

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook